How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | ELVElevance Health, Inc. | UNHUNITEDHEALTH GROUP INC | HUMHUMANA INC | CNCCENTENE CORP | Median of the restexcluding ELV |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $445.28▲ 11.15 (2.57%) | $424.98▲ 7.98 (1.91%) | $420.97▼ 4.45 (1.05%) | $71.24▲ 1.00 (1.42%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 6.0/10 | 6.0/10 | 4.7/10 | 6.0/10 |
| Market value | $98.28B | $385.03B | $50.79B | $35.03B | |
| Revenue | $199.13B | $447.57B | $129.66B | $174.58B | |
| Profit | $5.66B | $12.06B | $1.19B | -$6.67B | |
| Revenue growthChange in sales versus the prior year. | 12.5% | 11.8% | 10.1% | 20.0% | 11.8% |
| Gross marginShare of sales left after the direct cost of producing them. | 89.4% | 88.7% | — | 8.1% | 48.4% |
| Operating marginShare of sales left after running the business, before interest and tax. | 3.6% | 4.2% | 2.1% | -4.4% | 2.1% |
| Profit marginProfit kept from each dollar of sales. | 2.8% | 2.7% | 0.9% | -3.8% | 0.9% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 1.6% | 3.6% | 0.3% | 2.5% | 2.5% |
| Return on equityProfit against the owners' stake in the company. | 12.9% | 12.0% | 6.7% | -33.4% | 6.7% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 9.2% | 10.1% | 8.6% | -30.9% | 8.6% |
| P/E ratioPrice paid per dollar of annual profit. | 17.36x | 31.94x | 42.75x | — | 37.34x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 13.80x | 21.99x | 16.96x | — | 19.47x |
| Price to book | 2.24x | 3.85x | 2.88x | 1.76x | 2.88x |
| Debt to equityTotal liabilities compared with owners' stake. | 1.77x | 2.08x | 1.77x | 2.84x | 2.08x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 6/9 | 7/9 | 5/8 | 4/9 | 5.0 |
| Bankruptcy riskAltman Z-Score zone. | n/a for banks | n/a for banks | n/a for banks | n/a for banks |
How ELV compares with the others
- ELV's operating margin of 3.6% is higher than the median of the other companies selected (2.1%).
- Its revenue growth of 12.5% is in line with the median of the other companies selected (11.8%).
- It trades at a lower P/E than the median of the other companies selected: 17.4x against 37.3x.
- Its liabilities are lower relative to equity than the median of the other companies selected: 1.8x against 2.1x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.